We are live on !
Find out more
ING Group Portfolio holdings
AUM
$20.5B
Turnover
35.44%
1-Year Est. Return
49.71%
This Fund
S&P 500
This Quarter Est. Return
+10.24%
1 Year Est. Return
+49.71%
3 Year Est. Return
+147.48%
5 Year Est. Return
+191.43%
10 Year Est. Return
+667.03%
AUM
$7.44B
AUM Growth
-$584M
(-7.3%)
Cap. Flow
-$1.17B
Cap. Flow % of AUM
Cap. Flow %
-15.69%
Top 10 Holdings %
Top 10 Hldgs %
49.33%
Holding
664
New
135
Increased
183
Reduced
156
Closed
147
Avg Time Held
1.2
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blackstone
BX
|
+$252M |
| 2 |
Pfizer
PFE
|
+$135M |
| 3 |
Johnson & Johnson
JNJ
|
+$112M |
| 4 |
CY
Cypress Semiconductor
CY
|
+$112M |
| 5 |
Enterprise Products Partners
EPD
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$356M |
| 2 |
Energy Transfer Partners
ET
|
+$242M |
| 3 |
Mondelez International
MDLZ
|
+$191M |
| 4 |
Enbridge
ENB
|
+$138M |
| 5 |
MDVN
MEDIVATION, INC.
MDVN
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 36.16% |
| 2 | Financials | 19.48% |
| 3 | Technology | 9.83% |
| 4 | Materials | 9.47% |
| 5 | Healthcare | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Bank of America
BAC
$357B
| $747M | 10.05% |
56,348,622
+600,846
| +1% | +$8.44M |
2013 Q2
12 quarters
|
|
2
Air Products & Chemicals
APD
$68.6B
| $652M | 8.77% |
4,962,663
-339,056
| -6% | -$45.2M |
2015 Q4
2 quarters
|
|
|
3
Enterprise Products Partners
EPD
$78.9B
| $473M | 6.36% |
16,170,780
+4,147,645
| +34% | +$111M |
2013 Q2
12 quarters
|
|
|
ETP
4
DELISTED
Energy Transfer Partners L.p.
ETP
| $427M | 5.75% |
11,224,262
-1,722,920
| -13% | -$61.7M |
2014 Q4
6 quarters
|
|
|
5
Blackstone
BX
$94.8B
| $389M | 5.22% |
15,846,567
+9,477,059
| +149% | +$252M |
2013 Q2
12 quarters
|
|
|
WPZ
6
DELISTED
Williams Partners L.P.
WPZ
| $210M | 2.83% |
6,066,524
-847,273
| -12% | -$25.1M |
2015 Q4
2 quarters
|
|
|
7
Mondelez International
MDLZ
$83.2B
| $209M | 2.81% |
4,593,070
-4,386,881
| -49% | -$191M |
2013 Q2
12 quarters
|
|
|
ETP
8
DELISTED
Energy Transfer Partners, L.P.
ETP
| $195M | 2.62% |
6,775,032
+3,916,189
| +137% | +$108M |
2014 Q1
9 quarters
|
|
9
Apple
AAPL
$5.08T
| $190M | 2.56% |
7,967,844
-3,906,756
| -33% | -$97.1M |
2013 Q2
12 quarters
|
|
10
MPLX
MPLX
$59B
| $176M | 2.37% |
5,238,682
+1,375,800
| +36% | +$43.7M |
2015 Q1
5 quarters
|
|
|
MMP
11
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $149M | 2% |
1,954,475
-44,014
| -2% | -$3.12M |
2015 Q2
4 quarters
|
|
12
Plains All American Pipeline
PAA
$18.3B
| $148M | 1.99% |
5,391,003
-1,413,125
| -21% | -$34.2M |
2014 Q4
6 quarters
|
|
|
13
Energy Transfer Partners
ET
$69B
| $144M | 1.94% |
10,035,518
-20,292,332
| -67% | -$242M |
2013 Q2
12 quarters
|
|
|
14
Pfizer
PFE
$173B
| $142M | 1.91% |
+4,243,357
| New | +$135M |
2016 Q2
0 quarters
|
|
|
BWP
15
DELISTED
Boardwalk Pipeline Partners
BWP
| $128M | 1.72% |
7,338,580
+251,630
| +4% | +$4.16M |
2015 Q1
5 quarters
|
|
|
16
Johnson & Johnson
JNJ
$645B
| $126M | 1.7% |
1,041,308
+982,709
| +1,677% | +$112M |
2013 Q2
12 quarters
|
|
17
Microsoft
MSFT
$3.87T
| $124M | 1.67% |
2,432,011
+330,942
| +16% | +$17.2M |
2013 Q2
12 quarters
|
|
|
CY
18
DELISTED
Cypress Semiconductor
CY
| $124M | 1.66% |
+11,711,500
| New | +$112M |
2016 Q2
0 quarters
|
|
|
BPL
19
DELISTED
Buckeye Partners, L.P.
BPL
| $109M | 1.46% |
1,546,987
-454,987
| -23% | -$31.9M |
2014 Q3
7 quarters
|
|
20
iShares Core US Aggregate Bond ETF
AGG
$140B
| $104M | 1.39% |
919,076
| – | – |
2013 Q2
12 quarters
|
|
21
DELISTED
EMC CORPORATION
EMC
| $85.7M | 1.15% |
3,154,961
+692,916
| +28% | +$18.7M |
2013 Q2
12 quarters
|
|
|
EEP
22
DELISTED
Enbridge Energy Partners
EEP
| $83.9M | 1.13% |
3,613,927
+909,078
| +34% | +$19.3M |
2015 Q3
3 quarters
|
|
23
AbbVie
ABBV
$504B
| $83.2M | 1.12% |
+1,343,553
| New | +$81.9M |
2016 Q2
0 quarters
|
|
24
KKR & Co
KKR
$83.6B
| $63.8M | 0.86% |
5,172,092
-1,047,000
| -17% | -$14M |
2013 Q2
12 quarters
|
|
25
Intel
INTC
$452B
| $62.6M | 0.84% |
1,908,210
+1,262,888
| +196% | +$39.6M |
2013 Q2
12 quarters
|
|
Similar funds
ING Group's Q2 2016 Portfolio in Review
As of Q2 2016, ING Group held 664 positions worth $7.44B, down 7.3% from $8.02B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
ING Group withdrew a net $1.17B in Q2 2016, closing 147 positions and reducing 156 holdings. Its most notable exit was Enbridge, an estimated $138M position sold in full.
By sector, the portfolio is most concentrated in Energy at 36% of assets, up from 30% a quarter earlier, followed by Financials and Technology.
Against the trend, ING Group opened a new position in Pfizer worth $142M.
- ING Group's largest Q2 2016 buy was Pfizer: 4,243,357 shares worth $142M.
- ING Group added most to Blackstone in Q2 2016, an estimated $252M increase.
- ING Group's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $356M.
- ING Group fully exited Enbridge in Q2 2016, selling an estimated $138M.
- ING Group's ten largest holdings make up 49% of its $7.44B portfolio in Q2 2016.
- ING Group opened 135 new positions and closed 147 in Q2 2016.
- ING Group's portfolio value fell 7.3% quarter-over-quarter to $7.44B.
Based on ING Group's 13F filing for Q2 2016, filed 27 Jul 2016.